2005
DOI: 10.1016/j.jprocont.2004.08.003
|View full text |Cite
|
Sign up to set email alerts
|

First-principles and direct design approaches for the control of pharmaceutical crystallization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
301
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 305 publications
(302 citation statements)
references
References 59 publications
0
301
0
1
Order By: Relevance
“…One way to enhance the control of CSD is to use supersaturation control (SSC) (Aamir et al, 2009a;Braatz, 2002;Doki et al, 2004;Fujiwara et al, 2005;Liotta and Sabesan, 2004;Yu et al, 2006) or direct nucleation control (Abu Bakar et al, 2009aBakar et al, , 2009bWoo et al, 2009), which drives the process within the metastable zone to avoid nucleation, or to generate controlled nucleation/dissolution events, respectively. Although these approaches can provide improved consistency of the CSD, they do not address the actual design of the CSD.…”
Section: Introductionmentioning
confidence: 99%
“…One way to enhance the control of CSD is to use supersaturation control (SSC) (Aamir et al, 2009a;Braatz, 2002;Doki et al, 2004;Fujiwara et al, 2005;Liotta and Sabesan, 2004;Yu et al, 2006) or direct nucleation control (Abu Bakar et al, 2009aBakar et al, , 2009bWoo et al, 2009), which drives the process within the metastable zone to avoid nucleation, or to generate controlled nucleation/dissolution events, respectively. Although these approaches can provide improved consistency of the CSD, they do not address the actual design of the CSD.…”
Section: Introductionmentioning
confidence: 99%
“…It is also common to avoid nucleation by seeding with crystals of the desired polymorphic form, which will then grow. A large number of papers about crystallisation process control have focused on the control of some properties (e.g., weight, mean, size, aspect ratio) of the CSD [84,85,[149][150][151]. Fujiwara et al [151] reviewed the application of the first-principles and direct design methods to optimize and control pharmaceutical crystallisation processes.…”
Section: Optimisation and Control Of Crystal Size Distribution (Csd)mentioning
confidence: 99%
“…A large number of papers about crystallisation process control have focused on the control of some properties (e.g., weight, mean, size, aspect ratio) of the CSD [84,85,[149][150][151]. Fujiwara et al [151] reviewed the application of the first-principles and direct design methods to optimize and control pharmaceutical crystallisation processes. Either approach can be implemented with concentration-vs-temperature or temperature-vs-time setpoints, with these implementations having very different sensitivities to disturbances such as deviations in seed characteristics and changes in the contaminant profiles in the feed streams.…”
Section: Optimisation and Control Of Crystal Size Distribution (Csd)mentioning
confidence: 99%
See 2 more Smart Citations